Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hendrik Huedig is active.

Publication


Featured researches published by Hendrik Huedig.


Molecular & Cellular Proteomics | 2008

Comparative Proteomics Profiling of a Phospholamban Mutant Mouse Model of Dilated Cardiomyopathy Reveals Progressive Intracellular Stress Responses

Anthony O. Gramolini; Thomas Kislinger; Rasoul Alikhani-Koopaei; Vincent Fong; Natalie J. Thompson; Ruth Isserlin; Parveen Sharma; Gavin Y. Oudit; Maria G. Trivieri; Ailís Fagan; Anitha Kannan; Hendrik Huedig; George Hess; Sara Arab; Jonathan G. Seidman; Christine E. Seidman; Brendan J. Frey; Marc Perry; Peter H. Backx; Peter Liu; David H. MacLennan; Andrew Emili

Defective mobilization of Ca2+ by cardiomyocytes can lead to cardiac insufficiency, but the causative mechanisms leading to congestive heart failure (HF) remain unclear. In the present study we performed exhaustive global proteomics surveys of cardiac ventricle isolated from a mouse model of cardiomyopathy overexpressing a phospholamban mutant, R9C (PLN-R9C), and exhibiting impaired Ca2+ handling and death at 24 weeks and compared them with normal control littermates. The relative expression patterns of 6190 high confidence proteins were monitored by shotgun tandem mass spectrometry at 8, 16, and 24 weeks of disease progression. Significant differential abundance of 593 proteins was detected. These proteins mapped to select biological pathways such as endoplasmic reticulum stress response, cytoskeletal remodeling, and apoptosis and included known biomarkers of HF (e.g. brain natriuretic peptide/atrial natriuretic factor and angiotensin-converting enzyme) and other indicators of presymptomatic functional impairment. These altered proteomic profiles were concordant with cognate mRNA patterns recorded in parallel using high density mRNA microarrays, and top candidates were validated by RT-PCR and Western blotting. Mapping of our highest ranked proteins against a human diseased explant and to available data sets indicated that many of these proteins could serve as markers of disease. Indeed we showed that several of these proteins are detectable in mouse and human plasma and display differential abundance in the plasma of diseased mice and affected patients. These results offer a systems-wide perspective of the dynamic maladaptions associated with impaired Ca2+ homeostasis that perturb myocyte function and ultimately converge to cause HF.


Archive | 2008

Use of igfbp-7 in the assessment of heart failure

Ursula-Henrike Wienhues-Thelen; Georg Hess; Hendrik Huedig; Herbert von der Eltz; Andrew Emili; Anthony O. Gramolini; Peter Liu; David H. MacLennan; Vincent Fong; Ruth Isserlin; Thomas Kislinger; Dirk Block


Archive | 2007

METHOD FOR DIAGNOSING LIVER FIBROSIS

Ursula-Henrike Wienhues-Thelen; Paul Cales; Hendrik Huedig


Archive | 2010

Use of mimecan in the assessment of heart failure

Dirk Block; Sara Arab; Georg Hess; Hendrik Huedig; Peter Liu; Ursula-Henrike Wienhues-Thelen


Archive | 2010

USE OF ENDOSTATIN AS A MARKER OF HEART FAILURE

Ursula-Henrike Wienhues-Thelen; Dirk Block; Hendrik Huedig


Archive | 2007

Use of Nogo-C in the assessment of heart failure

Dirk Block; Georg Hess; Hendrik Huedig; Der Eltz Herbert Von; Ursula-Henrike Wienhues-Thelen; Andrew Emili; Vincent Fong; Anthony Gramolini; Ruth Isserlin; Thomas Kislinger; Peter Liu; David Maclennan


Archive | 2009

Use of slim-1 in the assessment of heart failure

Ursula-Henrike Wienhues-Thelen; Georg Hess; Hendrik Huedig; Herbert von der Eltz; Andrew Emili; Anthony O. Gramolini; Peter Liu; David H. MacLennan; Vincent Fong; Ruth Isserlin; Thomas Kislinger; Dirk Block


Archive | 2017

USE OF MIMECAN IN THE ASSESSMENT OF HEART FAILURE MIMECAN

Dirk Block; Sara Arab; Georg Hess; Hendrik Huedig; Peter Liu; Ursula-Henrike Wienhues-Thelen


Archive | 2012

ENDOSTATIN AS A MARKER OF HEART FAILURE

Ursula-Henrike Wienhues-Thelen; Dirk Block; Hendrik Huedig


Archive | 2011

Use of biglycan in the assessment of heart failure

Ursula-Henrike Wienhues-Thelen; Sara Arab; Dirk Block; Andrew Emili; Anthony Gramolini; Georg Hess; Hendrik Huedig; Peter Liu; David Maclennan

Collaboration


Dive into the Hendrik Huedig's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas Kislinger

Princess Margaret Cancer Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Emili

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge